Big Pharma: Trump vs. Harris is a showdown between two industry foes

The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.

By |2024-08-28T08:45:07-04:00August 28th, 2024|Latest News|0 Comments

Centene eliminates brokers’ commissions for Medicare drug plans

The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.

By |2024-08-28T08:41:55-04:00August 28th, 2024|Latest News|0 Comments

Health spending now exceeds prepandemic levels as utilization of care remains uneven

The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.

By |2024-08-27T09:02:39-04:00August 27th, 2024|Latest News|0 Comments

Value-Based Payment and Vanishing Small Independent Practices

The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.

By |2024-08-27T09:00:37-04:00August 27th, 2024|Latest News|0 Comments

Oregon plan cost-sharing cap ate 85% of hospital pay limit savings: Study

The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.

By |2024-08-27T08:59:41-04:00August 27th, 2024|Latest News|0 Comments

McKesson Signs Agreement to Acquire Controlling Interest in Florida Cancer Specialists & Research Institute’s Core Ventures

The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.

By |2024-08-26T08:38:18-04:00August 26th, 2024|Latest News|0 Comments